Exelixis, Inc. (EX9.DE)

EUR 32.28

(1.22%)

Inventory Summary of Exelixis, Inc.

  • Exelixis, Inc.'s latest annual inventory in 2023 was 17.32 Million USD , down -47.98% from previous year.
  • Exelixis, Inc.'s latest quarterly inventory in 2024 Q1 was 21.1 Million USD , up 21.84% from previous quarter.
  • Exelixis, Inc. reported annual inventory of 33.29 Million USD in 2022, up 21.12% from previous year.
  • Exelixis, Inc. reported annual inventory of 27.49 Million USD in 2021, up 31.09% from previous year.
  • Exelixis, Inc. reported quarterly inventory of 24.97 Million USD for 2023 Q3, down -12.77% from previous quarter.
  • Exelixis, Inc. reported quarterly inventory of 29.9 Million USD for 2023 Q1, down -10.18% from previous quarter.

Annual Inventory Chart of Exelixis, Inc. (2023 - 1998)

Historical Annual Inventory of Exelixis, Inc. (2023 - 1998)

Year Inventory Inventory Growth
2023 17.32 Million USD -47.98%
2022 33.29 Million USD 21.12%
2021 27.49 Million USD 31.09%
2020 20.97 Million USD 62.76%
2019 12.88 Million USD 30.98%
2018 9.83 Million USD 47.78%
2017 6.65 Million USD 99.43%
2016 3.33 Million USD 27.6%
2015 2.61 Million USD 9.87%
2014 2.38 Million USD -17.61%
2013 2.89 Million USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD -100.0%
2006 6.08 Million USD 11.76%
2005 5.44 Million USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD -100.0%
2000 3.61 Million USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%

Peer Inventory Comparison of Exelixis, Inc.

Name Inventory Inventory Difference
BioNTech SE 357.7 Million EUR 95.157%
CureVac N.V. 24.82 Million EUR 30.21%
Biotest Aktiengesellschaft 419.1 Million EUR 95.867%
Biotest Aktiengesellschaft 419.1 Million EUR 95.867%
BRAIN Biotech AG 9.72 Million EUR -78.11%
Formycon AG 467 Thousand EUR -3609.422%
Heidelberg Pharma AG 10.48 Million EUR -65.173%
Medigene AG 1.00 EUR -1732299900.0%